Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Clinical trial NCT05834855 · RECRUITING

Trial details

NCT number: NCT05834855
Sponsor: Amsterdam UMC, location VUmc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Demyelinating Autoimmune Diseases, CNS Autoimmune Diseases of the Nervous System Nervous System Diseases Demyelinating Diseases

Start date: 2023-04-01
Primary completion: 2027-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.